GlassScriptPhysician profile
Charles H Croft
NPI 1043296783
$13,955.29
in general payments reported to CMS, 2019-2025
46 companies · $1,706 in 2025
The $1,706 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,561 · 2020: $674 · 2021: $994 · 2022: $1,517 · 2023: $3,570 · 2024: $1,933 · 2025: $1,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,330 · Travel and Lodging: $1,879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,329.62 |
| Travel and Lodging | $1,878.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,708.34 | 2019-2025 | Amplatzer Amulet, Jot Dx, Aveir |
| Medtronic Vascular, INC. | $2,704.19 | 2019-2020 | |
| Shockwave Medical, INC | $1,105.38 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $714.81 | 2019-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $649.83 | 2019-2025 | |
| Abiomed | $644.38 | 2021-2025 | Impella |
| Janssen Pharmaceuticals, INC | $587.74 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $488.71 | 2021-2025 | Jardiance |
| Amgen INC. | $458.44 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $342.27 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $326.34 | 2020-2025 | Farxiga |
| Pfizer INC. | $314.52 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $260.03 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $255.51 | 2019-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $252.36 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $252.27 | 2021-2025 | Resolute Onyx, Micra, Concertotm |
| Biosense Webster, INC. | $171.00 | 2022-2024 | Nuvision Ice Catheter, Na |
| Daiichi Sankyo INC. | $147.08 | 2023-2025 | Injectafer |
| Esperion Therapeutics, INC. | $145.25 | 2021-2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $145.11 | 2024-2025 | Assure Wcd |
| Novo Nordisk INC | $131.99 | 2024-2025 | Wegovy |
| Amarin Pharma, INC. | $124.99 | 2019 | |
| Stryker Corporation | $123.81 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Biotronik INC. | $102.85 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $99.51 | 2023-2025 | Optimizer, Optimizer |
| Lexicon Pharmaceuticals, INC. | $89.21 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $87.31 | 2020-2023 | Kengreal |
| Teleflex LLC | $81.25 | 2023 | Trapliner |
| Cvrx, INC. | $53.09 | 2025 | Barostim Neo System |
| Opsens INC. | $39.41 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.36 | 2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $30.99 | 2025 | Uptravi |
| Coala Life INC | $30.50 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $30.22 | 2024 | Arcalyst |
| Penumbra, INC. | $28.67 | 2021-2025 | Indigo System |
| Ge Healthcare | $26.39 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $24.51 | 2025 | Evkeeza |
| Cordis US Corp. | $24.39 | 2025 | S.M.A.R.T. |
| Lundbeck LLC | $18.79 | 2019 | |
| Cardiovascular Systems INC. | $16.38 | 2021 | |
| Philips North America LLC | $15.88 | 2025 | IV Other |
| Medtronic USA, INC. | $15.24 | 2019 | |
| Scpharmaceuticals INC. | $14.53 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.25 | 2021 | |
| W. L. Gore & Associates, INC. | $13.99 | 2025 | Gore Acuseal Cardiovascular Patch Vascular |
| Cathworks, INC. | $12.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Croft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.